MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Real-life heart rate assessment: a digital biomarker for autonomic dysfunction in early Parkinson’s disease?

K. Veldkamp, L. Evers, Y. Raykov, M. Little, M. Brouwer, B. Bloem, J. Thannhauser (Nijmegen, Netherlands)

Meeting: 2023 International Congress

Abstract Number: 1803

Keywords: Autonomic dysfunction, Parkinson’s

Category: Technology

Objective: To assess whether 1) tremor and dyskinesia affect photoplethysmography (PPG) data quality, and 2) heart rate (HR) analysis based on continuous PPG can be used to quantify autonomic dysfunction in Parkinson’s disease (PD) patients.

Background: Autonomic dysfunction is an important non-motor sign of PD, and objective measures are needed to quantify its progression for both patient care and clinical trials.

Method: From the Personalized Parkinson Project cohort, we included 486 patients diagnosed with PD for < 5 years. Participants wore a wrist-worn sensor device (mean wear time of 20 hours per day), and we segmented the continuous PPG signal of the first study week into 1-min windows. Using a previously developed algorithm, we classified all windows into high- versus low-quality segments for HR analysis. First, we studied the correlation between the proportion of high-quality segments during the day, and the severity of rest tremor at the arm of the device (MDS-UPDRS item 3.17) and the severity of dyskinesia (MDS-UPDRS items 4.1 and 4.2). Second, we assessed the correlation between HR profiles and existing measures of autonomic dysfunction (the MDS-UPDRS part Ib subtotal). HR was calculated from each high-quality segment by deriving the dominant frequency in the power spectral density. We defined the resting HR as the modal HR over all segments (calculated separately for day- and night-time), and the maximum HR was set at the 99th percentile HR (daytime only).

Results: On average, 65% (IQR:  59 – 71) of the PPG data was classified as high-quality across all 486 patients. The proportion of high-quality PPG segments was not significantly different between patients with different severity of rest tremor (p = 0.46) and dyskinesia (p = 0.14). Patients with more severe non-motor symptoms demonstrated a significantly higher resting HR, both during the day (p = 0.04) and during the night (p = 0.04). Maximum HR was not significantly associated with non-motor symptom severity (p = 0.12).

Conclusion: This large study on real-life sensor-based monitoring of PD revealed no link between motor symptoms and PPG quality, and demonstrated associations between resting HR and autonomic symptoms. This suggests that PPG-based HR assessment could be a promising tool to objectively quantify autonomic dysfunction in PD patients.

HR Results

To cite this abstract in AMA style:

K. Veldkamp, L. Evers, Y. Raykov, M. Little, M. Brouwer, B. Bloem, J. Thannhauser. Real-life heart rate assessment: a digital biomarker for autonomic dysfunction in early Parkinson’s disease? [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/real-life-heart-rate-assessment-a-digital-biomarker-for-autonomic-dysfunction-in-early-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/real-life-heart-rate-assessment-a-digital-biomarker-for-autonomic-dysfunction-in-early-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley